Rapid development and deployment of high‐volume vaccines for pandemic response

Cited by (106)

Items 101–106 of 106

1. Computational design and immunoinformatic validation of a multistage mRNA vaccine candidate against Mycobacterium tuberculosis
   Manika Sharma, Parul Bhatt, Dr M K Singh, Kiran Bharat Lokhande, Shailendra Asthana, Monika Sharma, Sadhna Sharma · 2026 · In Silico Pharmacology
2. Current progress in developing mRNA-lipid nanoparticle vaccines against human bacterial pathogens
   Brody Pullinger, Nichaela Harbison-Price, Ismail Sebina, Jinrui Na, Gabrielle Therese Belz, Mark J. Walker · 2026 · Clinical Microbiology Reviews
3. Induction of mucosal immune responses against SARS-CoV-2: a heterologous intramuscular mRNA-LNP prime/pulmonary recombinant subunit pull vaccination strategy
   Melike Ongun, Naga Suresh Kola, Dhruv Patel, Tasson C. Rodrigues, S. Schmidt, Abhijeet Girish Lokras, Henrik Franzyk, Søren R. Paludan, Thomas Rades, Aneesh Thakur et al. · 2026 · Scientific Reports
4. In vitro transcription for RNA vaccines and therapeutics: a quality-by-design perspective on manufacturability
   Adithya Nair, Zoltán Kis · 2026 · Biotechnology Advances
5. Effects of natural killer cell depletion on innate and adaptive immune responses to COVID mRNA vaccination
   Allison Segard, Emilie Goguet, Hannah Haines-Hull, Kim C. Williamson, Stephen K. Anderson, Hooda Said, Mohamad‐Gabriel Alameh, Edward E.S. Mitre · 2026 · The Journal of Immunology
6. An Integrated Modeling Framework for Industrial Vaccine Manufacturing Based on Dynamic Bioprocess Simulation and Techno-Economic Analysis
   Lilibeth Niño, German Gelves · 2026 · South African Journal of Chemical Engineering